972.860.9659

The Science

SMART SCIENCEFrom Insight to Impact:
Molecular Innovation That Matters

 

What sets OSPRI apart is our fully integrated R&D model, where deep scientific expertise and experience converge to drive faster, smarter innovation. Major market players have kept PCR complex, time-consuming, and costly—ultimately limiting access and advancements. Unlike traditional manufacturers, we create forward-adaptive assays and platforms through our own microbiological, PCR, and NGS capabilities — ensuring our solutions not only meet today’s needs, but stay ahead of tomorrow’s emerging threats.

INDUSTRY PUBLICATIONS & RECOGNITION

Product
Catalog

White Papers and
Publications Library

RESEARCH & DEVELOPMENTThe Power of Our
Integrated R&D Model

Led by scientists with peer-reviewed publications in elite journals—including The New England Journal of Medicine—OSPRI’s R&D team is purpose-built for translational speed. We combine PhDs, clinical pathologists, microbiologists, and bioinformatics experts to rapidly develop molecular products that meet real-world needs.
  • Over 20 peer-reviewed publications since 2022
  • 5+ novel diagnostic workflows created in-house
  • NGS, PCR, and AMR experts under one roof;

Our scientists have contributed to scientific tools and standards used by the CDC, WHO, and public health agencies across the country. This includes important research on emerging infections, antimicrobial resistance (AMR), and new molecular technologies that have helped guide public health responses. Every OSPRI assay is built with frontline healthcare in mind — designed for speed, accuracy, and results you can act on. Over 15 clinical studies published since 2023 Products used in urgent cares, hospitals, outpatient centers, OB/GYN clinics, and more Cited in CDC’s Public Health Genomics & Precision Health Knowledge Base

Our regulatory framework lets us work directly with groups like the U.S. Department of Defense, NIH, BARDA, and state public health systems— all with confidence and precision. Whether it’s advancing new molecular technologies or contributing to federally funded research, our accredited laboratories and processes help us deliver fast, accurate, and compliant solutions. These certifications aren’t just credentials — they help open doors to new opportunities for impact.CLIA Certification – High-complexity clinical lab designation CAP Accreditation – Gold standard in laboratory quality ISO 9001:2015 – Global benchmark for operational quality ISO 13485:2016 – QMS for medical device design and development cGMP Compliance – Ensures alignment with manufacturing best practices CAGE Code and UEI – Active for federal grant submission and DOD procurement

No single method is enough.

 

When OSPRI develops a diagnostic tool to detect multiple pathogens, it doesn’t rely on a single method. Instead, OSPRI integrates expertise across three major scientific disciplines to build assays that are both comprehensive and clinically precise:

Technology
Cost
Pathogen Detection
Speed
Technology

Microbiology

Cost

Low cost, low barrier to entry

Pathogen Detection

Agnostic — can detect any pathogen eventually

Speed

Very slow (1–14 days); manual

Technology

PCR

Cost

Higher cost, higher barrier to entry

Pathogen Detection

Pathogen-specific — detects only what the assay targets

Speed

Fastest, cost-effective (<4 hours)

Technology

Next-Gen Sequencing (NGS)

Cost

Highest cost, highest barrier to entry

Pathogen Detection

Agnostic — detects any pathogen immediately

Speed

Fast broad-spectrum detection (<4 hours)

Science Without Silos.
Innovation 
Without Limits.

MODELWhy Our Model Matters

Comprehensive Understanding

Holistic insight across biological and genetic levels ensures broader, more relevant detection.

Faster Innovation

Cross-functional collaboration accelerates discovery and shortens time-to-market.

Precision & Accuracy

OSPRI labs scale smarter with fewer tools and staff, achieving with two machines what others need ten for.

Direct-to-PCR

Extraction-free assay means less time, fewer steps, and lower cost.

Direct-to-Amplification

Pre-plated or pre-mixed reagents are ready “out of the box,” eliminating prep time.

Multiplexing

Quad-plex format enables four targets per well, reducing thermal cycles, increasing sample throughput, and driving down cost per test.

Customization

Flexible assay design allows providers to test for what matters — improving clinical relevance and reducing claim denials.

That’s the power behind every OSPRI solution—and how to optimize outcomes every day.

“Innovation is seeing what
everybody has seen and thinking
what nobody has thought.”

Dr. Albert Szent-Györgyi

Where innovation meets action—optimize every outcome with OSPRI.

Contact Us

Contact Us

Connect with us for inquiries or
collaboration opportunities